Black Diamond Therapeutics Inc (BDTX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -114.749 | -29.846 | -33.56 | -27.565 | -43.508 | -45.14 | -52.374 |
Return on Equity (%) | 137.888 | 80.398 | 112.468 | -51.615 | -49.874 | -58.518 | -70.939 |
Return on Invested Capital (%) | -142.575 | -34.919 | -29.897 | -30.418 | -53.602 | -67.555 | -75.039 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.882 | 6.755 | 68.581 | 8.53 | 5.407 | 3.175 | 2.261 |
Earnings Per Share | -0.702 | -1.334 | -15.761 | -1.864 | -3.466 | -2.502 | -1.597 |
Cash Per Share | 1.202 | 7.716 | 69.14 | 0.959 | 1.816 | 0.942 | 1.089 |
Working Capital Per Share | 0.867 | 7.335 | 67.435 | 8.463 | 5.301 | 3.086 | 2.215 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.702 | -1.334 | -15.761 | -1.864 | -3.466 | -2.502 | -1.597 |
EBITDA Per Share | -0.702 | -1.334 | -15.761 | -1.864 | -3.466 | -2.502 | -1.597 |
Free Cash Flow Per Share | -0.694 | -1.329 | -15.773 | -1.862 | -3.397 | -2.511 | -1.604 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 6,56M | 6,7M | 2,24M | 36,08M | 36,23M | 36,43M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 36,43M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 138,63M |
Ratio cours/bénéfice | -1,7 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 2,49 |
Ratio prix/valeur comptable | 1,2 |
Rendement de dividende | - |
Actions en circulation | 56,59M |
Volume moyen (1 semaine) | 860,37k |
Volume moyen (1 mois) | 1,46M |
Variation sur 52 semaines | -10,76% |
Plus haut sur 52 semaines | 7,66 |
Plus bas sur 52 semaines | 1,91 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales